产品: CD133 抗体
货号: AF5120
描述: Rabbit polyclonal antibody to CD133
应用: WB IHC IF/ICC
反应: Human, Mouse, Rat
分子量: 97 kDa; 97kD(Calculated).
蛋白号: O43490
RRID: AB_2837606

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human,Mouse,Rat
克隆:
Polyclonal
特异性:
CD133 Antibody detects endogenous levels of total CD133.
RRID:
AB_2837606
引用格式: Affinity Biosciences Cat# AF5120, RRID:AB_2837606.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

AC133; Antigen AC133; CD133; CORD12; Hematopoietic stem cell antigen; hProminin; MCDR2; MSTP061; OTTHUMP00000217744; OTTHUMP00000217745; OTTHUMP00000217746; PROM1; PROM1_HUMAN; Prominin I; Prominin like 1; Prominin like protein 1 precursor; Prominin mouse like 1; Prominin-1; Prominin-like protein 1; Prominin1; PROML1; RP41; STGD4;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
表达:
O43490 PROM1_HUMAN:

Isoform 1 is selectively expressed on CD34 hematopoietic stem and progenitor cells in adult and fetal bone marrow, fetal liver, cord blood and adult peripheral blood. Isoform 1 is not detected on other blood cells. Isoform 1 is also expressed in a number of non-lymphoid tissues including retina, pancreas, placenta, kidney, liver, lung, brain and heart. Found in saliva within small membrane particles. Isoform 2 is predominantly expressed in fetal liver, skeletal muscle, kidney, and heart as well as adult pancreas, kidney, liver, lung, and placenta. Isoform 2 is highly expressed in fetal liver, low in bone marrow, and barely detectable in peripheral blood. Isoform 2 is expressed on hematopoietic stem cells and in epidermal basal cells (at protein level). Expressed in adult retina by rod and cone photoreceptor cells (at protein level).

描述:
CD133, originally known as AC133. CD133 is a glycoprotein also known in humans and rodents as Prominin 1 (PROM1). Currently the function of CD133 is unknown. It is a member of pentaspan transmembrane glycoproteins (5-transmembrane, 5-TM), which specifically localize to cellular protrusions. CD133 is expressed in hematopoietic stem cells
序列:
MALVLGSLLLLGLCGNSFSGGQPSSTDAPKAWNYELPATNYETQDSHKAGPIGILFELVHIFLYVVQPRDFPEDTLRKFLQKAYESKIDYDKPETVILGLKIVYYEAGIILCCVLGLLFIILMPLVGYFFCMCRCCNKCGGEMHQRQKENGPFLRKCFAISLLVICIIISIGIFYGFVANHQVRTRIKRSRKLADSNFKDLRTLLNETPEQIKYILAQYNTTKDKAFTDLNSINSVLGGGILDRLRPNIIPVLDEIKSMATAIKETKEALENMNSTLKSLHQQSTQLSSSLTSVKTSLRSSLNDPLCLVHPSSETCNSIRLSLSQLNSNPELRQLPPVDAELDNVNNVLRTDLDGLVQQGYQSLNDIPDRVQRQTTTVVAGIKRVLNSIGSDIDNVTQRLPIQDILSAFSVYVNNTESYIHRNLPTLEEYDSYWWLGGLVICSLLTLIVIFYYLGLLCGVCGYDRHATPTTRGCVSNTGGVFLMVGVGLSFLFCWILMIIVVLTFVFGANVEKLICEPYTSKELFRVLDTPYLLNEDWEYYLSGKLFNKSKMKLTFEQVYSDCKKNRGTYGTLHLQNSFNISEHLNINEHTGSISSELESLKVNLNIFLLGAAGRKNLQDFAACGIDRMNYDSYLAQTGKSPAGVNLLSFAYDLEAKANSLPPGNLRNSLKRDAQTIKTIHQQRVLPIEQSLSTLYQSVKILQRTGNGLLERVTRILASLDFAQNFITNNTSSVIIEETKKYGRTIIGYFEHYLQWIEFSISEKVASCKPVATALDTAVDVFLCSYIIDPLNLFWFGIGKATVFLLPALIFAVKLAKYYRRMDSEDVYDDVETIPMKNMENGNNGYHKDHVYGIHNPVMTSPSQH

翻译修饰 - O43490 作为底物

Site PTM Type Enzyme
Y34 Phosphorylation
K82 Acetylation
Y219 Phosphorylation
K225 Acetylation
K257 Acetylation
K264 Acetylation
T266 Phosphorylation
S275 Phosphorylation
T276 Phosphorylation
S719 Phosphorylation
S733 Phosphorylation
T739 Phosphorylation
S824 Phosphorylation
Y828 Phosphorylation P12931 (SRC) , P06241 (FYN)
T833 Phosphorylation
Y852 Phosphorylation P12931 (SRC) , P06241 (FYN)
S863 Phosphorylation

研究背景

功能:

May play a role in cell differentiation, proliferation and apoptosis. Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis. Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner.

翻译修饰:

Isoform 1 and isoform 2 are glycosylated.

Acetylation at Lys-225, Lys-257 and Lys-264 by NAT8 and NAT8B may control PROM1 protein expression and its function in cell apoptosis.

细胞定位:

Apical cell membrane>Multi-pass membrane protein. Cell projection>Microvillus membrane>Multi-pass membrane protein. Cell projection>Cilium>Photoreceptor outer segment. Endoplasmic reticulum. Endoplasmic reticulum-Golgi intermediate compartment.
Note: Found in extracellular membrane particles in various body fluids such as cerebrospinal fluid, saliva, seminal fluid and urine.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
组织特异性:

Isoform 1 is selectively expressed on CD34 hematopoietic stem and progenitor cells in adult and fetal bone marrow, fetal liver, cord blood and adult peripheral blood. Isoform 1 is not detected on other blood cells. Isoform 1 is also expressed in a number of non-lymphoid tissues including retina, pancreas, placenta, kidney, liver, lung, brain and heart. Found in saliva within small membrane particles. Isoform 2 is predominantly expressed in fetal liver, skeletal muscle, kidney, and heart as well as adult pancreas, kidney, liver, lung, and placenta. Isoform 2 is highly expressed in fetal liver, low in bone marrow, and barely detectable in peripheral blood. Isoform 2 is expressed on hematopoietic stem cells and in epidermal basal cells (at protein level). Expressed in adult retina by rod and cone photoreceptor cells (at protein level).

亚基结构:

Interacts with CDHR1 and with actin filaments. Interacts with NAT8 and NAT8B.

蛋白家族:

Belongs to the prominin family.

研究领域

· Human Diseases > Cancers: Overview > Transcriptional misregulation in cancer.

文献引用

1). Characteristics of expression of cancer stem cell markers in various approaches to cervical cancer treatment.. Journal of Clinical Oncology, 2022 [IF=45.3]

2). HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial–mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation. Acta Pharmaceutica Sinica B, 2021 (PubMed: 34221870) [IF=14.5]

Application: WB    Species: Human    Sample: HepG2 cells

Figure 5 Tumor spheres isolated from hepatocellular carcinoma HepG2 cells obtained the characteristics of cancer stem cells. (A) Comparison of the protein levels of CD133 and CD44 in HCCLM3 and HepG2 cells. The protein expression of (B) CD133 and (C) CD44 was dramatically increased in HepG2 cells compared with those in HCCLM3 cells. * P<0.05, compared with the HCCLM3 cells. (D) The images of 3D tumor spheroids were captured using the fluorescence microscope every three days of Day 0 in attachment surface plates and Days 0, 3, 5, 7, and 10 in ultra-low attachment surface plates with CSC medium (magnification 200×); scale bar: 20 μm. (E) The protein expression of CD133 and CD44 was analyzed by Western blot in HepG2 and CSC-like cells. The protein expression of (F) CD133 and (G) CD44 was dramatically increased in CSC-like cells compared with HepG2 cells. Data are presented as mean±SEM; * P<0.05, ** P<0.01. (H) The expression of CD133 and CD44 were assessed by immunofluorescence staining in HepG2 and tumor sphere cells. Blue represents DAPI; green represents CD44; red represents CD133. Magnification: 400×. (I) CSC augments tumor-initiating in vivo. Representative xenograft tumors derived from CSC-like cells compared to HepG2 cells after two weeks subcutaneous injection in nude mice (n=3). Left panel: HepG2 cells; right: CSCs. (J) The protein levels of CD133 and CD44 were analyzed by Western blot in the tumor tissues isolated from xenograft models. GAPDH served as a sample loading control. The protein levels of CSC markers (K) CD133 and (L) CD44 were dramatically upregulated in right tissues compared with left tissues. Data are presented as mean±SEM; * P < 0.05, *** P< 0.001.

Application: IF/ICC    Species: Human    Sample: HepG2 cells

Figure 5 Tumor spheres isolated from hepatocellular carcinoma HepG2 cells obtained the characteristics of cancer stem cells. (A) Comparison of the protein levels of CD133 and CD44 in HCCLM3 and HepG2 cells. The protein expression of (B) CD133 and (C) CD44 was dramatically increased in HepG2 cells compared with those in HCCLM3 cells. * P<0.05, compared with the HCCLM3 cells. (D) The images of 3D tumor spheroids were captured using the fluorescence microscope every three days of Day 0 in attachment surface plates and Days 0, 3, 5, 7, and 10 in ultra-low attachment surface plates with CSC medium (magnification 200×); scale bar: 20 μm. (E) The protein expression of CD133 and CD44 was analyzed by Western blot in HepG2 and CSC-like cells. The protein expression of (F) CD133 and (G) CD44 was dramatically increased in CSC-like cells compared with HepG2 cells. Data are presented as mean±SEM; * P<0.05, ** P<0.01. (H) The expression of CD133 and CD44 were assessed by immunofluorescence staining in HepG2 and tumor sphere cells. Blue represents DAPI; green represents CD44; red represents CD133. Magnification: 400×. (I) CSC augments tumor-initiating in vivo. Representative xenograft tumors derived from CSC-like cells compared to HepG2 cells after two weeks subcutaneous injection in nude mice (n=3). Left panel: HepG2 cells; right: CSCs. (J) The protein levels of CD133 and CD44 were analyzed by Western blot in the tumor tissues isolated from xenograft models. GAPDH served as a sample loading control. The protein levels of CSC markers (K) CD133 and (L) CD44 were dramatically upregulated in right tissues compared with left tissues. Data are presented as mean±SEM; * P < 0.05, *** P< 0.001.

3). TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling. Theranostics, 2022 (PubMed: 35673564) [IF=12.4]

Application: IF/ICC    Species: Human    Sample:

TGFBI mediates the tumor-promoting effect of M2-like TAMs. (A) Representative immunofluorescence (IF) staining of TGFBI and stem cell markers (CD133, Olig2) in human GBM were shown. Nuclei were counterstained with DAPI (blue). Scale bar represents 20 µm. (B) Representative tumorsphere images of GSCs (456 and 3691) cultured with rhTGFBI or control for 48 hours. Scale Bar: 400 µm. (C) Quantification of tumorspheres in (B). N = 3, **p < 0.01, Student's t-test. (D, E) Cell viability (D) and in vitro limiting dilution (E) assay of GSCs (456 and 3691) cultured with rhTGFBI or control. N = 6 biological independent samples. Data were represented as means ± SD, ****p < 0.0001, Student's t-test (D); *p < 0.05, likelihood ratio test (E). (F) Representative IF images of EdU incorporation. Scale bar represents 20 µm. (G) The quantification of the percentage of EdU+ cells. N = 3, *p < 0.05, **p < 0.01, Student's t-test. (H) IB analysis showed the extent of TGFBI knockdown in M2 macrophages. GAPDH was used as a loading control. (I) Representative HE staining of mouse brain (cross-section) 25 days after transplantation. Scale bar represents one cm. (J) Representative IF images of Ki67 in mouse models. Scale bar represents 200 µm. (K) Kaplan-Meier survival plot of mice co-implanted with GSCs (456) and shTGFBI M2 macrophages or shNT M2 macrophages. N = 9 for each group, **p < 0.01, ***p < 0.001, log-rank test.

4). Polysaccharide from Flammulina velutipes residues protects mice from Pb poisoning by activating Akt/GSK3β/Nrf-2/HO-1 signaling pathway and modulating gut microbiota. International Journal of Biological Macromolecules, 2023 (PubMed: 36610568) [IF=8.2]

5). Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice. The Journal of pathology, 2021 (PubMed: 34410012) [IF=7.3]

6). Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer. BMC Cancer, 2020 (PubMed: 32891131) [IF=3.8]

Application: IHC    Species: Human    Sample:

Fig. 3 CD133 expression was associated with age and prognosis of LARC patients. (a) and (b) Cut-off points for CD133 expression determined by the X-tile program. X-tile analysis divided the entire cohort into the training (shown in the upper-left quartile of A) and matched validation sets (shown on the bottom X-axis of A) based on patient survival data. The black dot in the validation set represents the exact cut-off value for CD133 expression. The entire cohort was divided into low (blue) and high (gray) NLR count groups based on the optimal cut-point, as is shown on a histogram of the entire cohort (b). (c) Kaplan–Meier curve of disease-free survival and (d) overall survival for the optimal cut-point of the CD133 expression. Representative figures of expression of CD133 in rectal cancer tissues (10 × 40), (e) Negative (−), (f) Weakly positive (+), (g) Positive (++), (h) Strongly positive (+++). (i) The CD133 expression scores in the young and old groups. (j) The correlation analysis of CD133 expression score and patient age. (k) The CD133 expression scores in the pCR and non-pCR groups. (l) Kaplan–Meier curve of disease-free survival and (m) overall survival for the young and old group

7). ЭКСПРЕССИЯ МАРКЕРОВ ОПУХОЛЕВЫХ СТВОЛОВЫХ КЛЕТОК ПРИПЕРВИЧНОМ С РАЗЛИЧНОЙ СТАДИЕЙ И ГЛУБИНОЙ ИНВАЗИИ ИРЕЦИДИВНОМ РАКЕ ВУЛЬВЫ. , 2021

8). PU.1 alleviates the inhibitory effects of cigarette smoke on endothelial progenitor cell function and lung-homing through Wnt/β-catenin and CXCL12/CXCR4 pathways. Tobacco Induced Diseases, 2024 (PubMed: 38274000)

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.